Methodological characteristics and treatment effect sizes in oral health randomised controlled trials: Is there a relationship? Protocol for a meta-epidemiological study

被引:7
作者
Saltaji, Humam [1 ]
Armijo-Olivo, Susan [2 ,3 ]
Cummings, Greta G. [3 ]
Amin, Maryam [4 ]
Flores-Mir, Carlos [5 ]
机构
[1] Univ Alberta, Sch Dent, Orthodont Grad Program, Edmonton, AB, Canada
[2] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada
[3] Univ Alberta, Fac Nursing, Edmonton, AB, Canada
[4] Univ Alberta, Sch Dent, Div Pediat Dent, Edmonton, AB, Canada
[5] Univ Alberta, Sch Dent, Div Orthodont, Edmonton, AB, Canada
来源
BMJ OPEN | 2014年 / 4卷 / 02期
关键词
Oral & Maxillofacial Surgery; Oral Medicine; ALLOCATION CONCEALMENT; EMPIRICAL-EVIDENCE; PHYSICAL-THERAPY; QUALITY; BIAS; METAANALYSES; ASSOCIATION; EXPLANATION; GUIDELINES; EVALUATE;
D O I
10.1136/bmjopen-2013-004527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction It is fundamental that randomised controlled trials (RCTs) are properly conducted in order to reach well-supported conclusions. However, there is emerging evidence that RCTs are subject to biases which can overestimate or underestimate the true treatment effect, due to flaws in the study design characteristics of such trials. The extent to which this holds true in oral health RCTs, which have some unique design characteristics compared to RCTs in other health fields, is unclear. As such, we aim to examine the empirical evidence quantifying the extent of bias associated with methodological and non-methodological characteristics in oral health RCTs. Methods and analysis We plan to perform a meta-epidemiological study, where a sample size of 60 meta-analyses (MAs) including approximately 600 RCTs will be selected. The MAs will be randomly obtained from the Oral Health Database of Systematic Reviews using a random number table; and will be considered for inclusion if they include a minimum of five RCTs, and examine a therapeutic intervention related to one of the recognised dental specialties. RCTs identified in selected MAs will be subsequently included if their study design includes a comparison between an intervention group and a placebo group or another intervention group. Data will be extracted from selected trials included in MAs based on a number of methodological and non-methodological characteristics. Moreover, the risk of bias will be assessed using the Cochrane Risk of Bias tool. Effect size estimates and measures of variability for the main outcome will be extracted from each RCT included in selected MAs, and a two-level analysis will be conducted using a meta-meta-analytic approach with a random effects model to allow for intra-MA and inter-MA heterogeneity. Ethics and dissemination The intended audiences of the findings will include dental clinicians, oral health researchers, policymakers and graduate students. The aforementioned will be introduced to the findings through workshops, seminars, round table discussions and targeted individual meetings. Other opportunities for knowledge transfer will be pursued such as key dental conferences. Finally, the results will be published as a scientific report in a dental peer-reviewed journal.
引用
收藏
页数:6
相关论文
共 39 条
  • [1] The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
    Altman, DG
    Schulz, KF
    Moher, D
    Egger, M
    Davidoff, F
    Elbourne, D
    Gotzsche, PC
    Lang, T
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) : 663 - 694
  • [2] American Dental Association, SPEC DEF
  • [3] How should we evaluate the risk of bias of physical therapy trials?: a psychometric and meta-epidemiological approach towards developing guidelines for the design, conduct, and reporting of RCTs in Physical Therapy (PT) area: a study protocol.
    Armijo-Olivo S.
    Fuentes J.
    Rogers T.
    Hartling L.
    Saltaji H.
    Cummings G.G.
    [J]. Systematic Reviews, 2 (1) : 88
  • [4] Inconsistency in the items included in tools used in general health research and physical therapy to evaluate the methodological quality of randomized controlled trials: a descriptive analysis
    Armijo-Olivo, Susan
    Fuentes, Jorge
    Ospina, Maria
    Saltaji, Humam
    Hartling, Lisa
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13
  • [5] Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials
    Balk, EM
    Bonis, PAL
    Moskowitz, H
    Schmid, CH
    Ioannidis, JPA
    Wang, CC
    Lau, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (22): : 2973 - 2982
  • [6] Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI [10.4324/9780203771587, DOI 10.4324/9780203771587]
  • [7] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [8] Dumbrigue Herman B, 2006, J Prosthodont, V15, P257, DOI 10.1111/j.1532-849X.2006.00115.x
  • [9] Egger M, 2003, Health Technol Assess, V7, P1
  • [10] The effect of bias on the magnitude of clinical outcomes in periodontology: a pilot study
    Fenwick, Julie
    Needleman, Ian G.
    Moles, David R.
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2008, 35 (09) : 775 - 782